WVE-006 clinical trials

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

This study looks at a new medicine called WVE-006 for a genetic lung and liver condition called Alpha-1 Antitrypsin Deficiency (AATD). It aims to see if the medicine is safe, how much good it does, and how the body handles it in people with AATD.